FDA.reportPublic FDA data

brimonidine tartrate 1 MG/ML Ophthalmic Solution

RxCUI
861204
RxNorm name
brimonidine tartrate 1 MG/ML Ophthalmic Solution
Display name
brimonidine tartrate 1 MG/ML Ophthalmic Solution
Full name
brimonidine tartrate 1 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
brimonidine tartrateBRIMONIDINE TARTRATEMicro Labs Limited981a75cd-2487-40e4-911a-26de2aa98dc12026-05-21Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine Tartrate Ophthalmic SolutionBRIMONIDINE TARTRATE OPHTHALMIC SOLUTIONLifestar Pharma LLCf6666d85-f810-4869-993d-e8ae35b4517f2026-04-17Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine TartrateBRIMONIDINE TARTRATEGland Pharma Limitede4b04ef1-6586-4386-a844-2c5fc3bd4a8f2026-03-12Warnings, Adverse reactionsExact identifier
rxcui: 861204
BrimonidineBRIMONIDINE TARTRATESandoz Inc87c5a534-4321-46c7-9938-84dca34b65062025-10-07Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine TartrateBRIMONIDINE TARTRATEApotex Corp.e08a915a-77ca-4d16-d760-11b05848418d2025-09-25Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine tartrateBRIMONIDINE TARTRATEPacific Pharma, Inc.5c4aea88-95ca-4da8-a3da-02f10c8b66232025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 861204
ALPHAGAN PBRIMONIDINE TARTRATEAllergan, Inc.264c4494-c225-486f-888a-caaf36be46b32025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 861204
BRIMONIDINE TARTRATEBRIMONIDINE TARTRATESomerset Therapeutics, LLCb8e108b3-aca8-4e3e-8577-37ac796148c32024-08-26Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine TartrateBRIMONIDINE TARTRATEAlembic Pharmaceuticals Limitedee26e0c9-a169-4842-ab0f-3c718bb140182023-08-28Warnings, Adverse reactionsExact identifier
rxcui: 861204
Brimonidine TartrateBRIMONIDINE TARTRATEAlembic Pharmaceuticals Inc.9da815fb-6454-4925-9150-bec40eff9c2d2023-08-11Warnings, Adverse reactionsExact identifier
rxcui: 861204

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
264c4494-c225-486f-888a-caaf36be46b3brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]324These highlights do not include all the information needed to use ALPHAGAN P safely and effectively. See full prescribing information for ALPHAGAN P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% , for topical ophthalmic use Initial U.S. Approval: 199620250918
87c5a534-4321-46c7-9938-84dca34b6506brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]315These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.1%, for topical ophthalmic use Initial U.S. Approval: 199620251007
5c4aea88-95ca-4da8-a3da-02f10c8b6623brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]311These highlights do not include all the information needed to use Brimonidine tartrate ophthalmic solution 0.1% and 0.15% safely and effectively. See full prescribing information for brimonidine tartrate ophthalmic solution 0.1% and 0.15%. Brimonidine tartrate ophthalmic solution 0.1% and 0.15% Initial U.S. Approval: 199620250918
e4b04ef1-6586-4386-a844-2c5fc3bd4a8fbrimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]36These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution 0.1%, for topical ophthalmic use Initial U.S. Approval: 199620260312
9da815fb-6454-4925-9150-bec40eff9c2dbrimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]35These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE Ophthalmic Solution Initial U.S. Approval: 199620230811
e08a915a-77ca-4d16-d760-11b05848418dbrimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]34These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE ophthalmic solution 0.1%, for topical ophthalmic use Initial U.S. Approval: 199620250925
b8e108b3-aca8-4e3e-8577-37ac796148c3brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]34These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION BRIMONIDINE TARTRATE ophthalmic solution Initial U.S. Approval: 199620240826
ba15fa83-c808-4298-bb0e-43ed1429c526brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]34These highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 199620130315
ee26e0c9-a169-4842-ab0f-3c718bb14018brimonidine tartrate 0.1 % Ophthalmic Solution [PSN] · brimonidine tartrate 1 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.1 % Ophthalmic Solution [SY]31These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE Ophthalmic Solution Initial U.S. Approval: 199620230828